United States

For the children: Stuart W. Peltz, Ph.D.; CEO; PTC Therapeutics


A biotech company specializing in rare children's diseases, PTC has experienced significant growth in the personalized medicine arena. Despite the coronavirus lockdown, CEO Dr. Stuart Peltz and his team have continued to develop innovative, safe and effective therapeutics to treat young patients.

Watch the full episode, or highlights about risk and uncertainty, workforce dynamics, policy and legislation, and leadership lessons.